OncXerna Therapeutics
Waltham, US · Founded 2018 · Cayman Islands corporation · 1 known investors
Founders & leadership
CB
Chrystiyna BedrijNamed on SEC filing
PB
Peter BisgaardNamed on SEC filing
VC
Vincent CheungNamed on SEC filing
LB
Laura BenjaminNamed on SEC filing
BC
Benjamin ChenNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$30M disclosed across 1 round · 2022
▶$30MraisedMar 2022 · 4 investors · BiotechnologyRule 506(b)
▶$30MraisedMar 2022 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chrystiyna BedrijDirector
- Peter BisgaardDirector
- Vincent CheungDirector
- Laura BenjaminDirector
- Benjamin ChenDirector
- Offering amount
- $100M
- Amount sold
- $30M
- First sale
- Feb 2022
- Incorporated
- Corporation, Cayman Islands, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are OncXerna Therapeutics's investors?
- OncXerna Therapeutics's investors include K2 HealthVentures.
- How much funding has OncXerna Therapeutics raised?
- OncXerna Therapeutics has disclosed $30M raised across 1 round.
- Where is OncXerna Therapeutics headquartered?
- OncXerna Therapeutics is headquartered in Waltham, US.